Figuring out who to screen could change the game. This discovery is getting us closer.

Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to ...

University Health Network's Toronto General Hospital has ranked second in the world in Newsweek magazine's World's Best Hospitals 2026, marking the highest position ever achieved by a Canadian ...

Studying gene expression in a cancer patient's cells can help clinical biologists understand the cancer's origin and predict the success of different treatments. But cells are complex and contain many ...

UD developmental biologist studies genetics of jaw joint disorder with NIH funding ...

Immunexpress, a molecular diagnostics company focused on improving outcomes for patients with suspected sepsis, today ...

Researchers mapped nearly 91,000 healthy bone marrow cells from donors aged two to 32, creating the first pediatric atlas.

Priya Hays, Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and ...

The ‘MYCN’ gene creates a specific nook that turns healthy liver cells into cancer. Detecting MYCN gene early could help identify and reduce liver cancer risk.

Hoot Health today announced its entry into the pharmaceutical market with an AI-powered, physician-led patient education engine designed to address one of the industry's most costly challenges: failed ...

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' ...

Studying gene expression in a cancer patient's cells can help clinical biologists understand the cancer's origin and predict ...